International Association for the Study of Lung Cancer

International Association for the Study of Lung Cancer Bookmark us: http://www.iaslc.org/ or Follow us on Twitter:@iaslc Become a member of the IASLC:
http://www.iaslc.org/become_a_member.asp

Operating as usual

One Week Away! Register Now for SCLC21! SCLC21 is focused on preclinical and clinical advances in SCLC research, and inc...
10/21/2021

One Week Away! Register Now for SCLC21! SCLC21 is focused on preclinical and clinical advances in SCLC research, and includes two keynotes, a dedicated session for early-career investigators, and educational sessions discussing the latest in biomarkers and liquid biopsy; novel pathways and targets; clinical trials, mouse models, and immunotherapy. Additionally, attendees will have the chance to network with like-minded professionals and fellow investigators, paving the way for long-term collaborations and future research breakthroughs. Register today at https://bit.ly/3ppaD2G

One Week Away! Register Now for SCLC21! SCLC21 is focused on preclinical and clinical advances in SCLC research, and includes two keynotes, a dedicated session for early-career investigators, and educational sessions discussing the latest in biomarkers and liquid biopsy; novel pathways and targets; clinical trials, mouse models, and immunotherapy. Additionally, attendees will have the chance to network with like-minded professionals and fellow investigators, paving the way for long-term collaborations and future research breakthroughs. Register today at https://bit.ly/3ppaD2G

Join us for the 2021 LALCA Schools of Thoracic Oncology - Worldwide Virtual Event on December 3-4, 2021, the largest tho...
10/20/2021

Join us for the 2021 LALCA Schools of Thoracic Oncology - Worldwide Virtual Event on December 3-4, 2021, the largest thoracic oncology event in LATAM!

The program includes sessions across four schools including: Thoracic Oncology, Nursing & Allied Health Professionals, Advocacy, and Pathology; A panel of experts will highlight palliative care and pain management best practices, medical ma*****na controversies and cancer indications, integrative medicine in the region, and a LIVE Q&A. Early Registration closes November 10, 2021. You can view the Program and/or Register Here: http://ow.ly/55DD50GubKi #LALCA21

Join us for the 2021 LALCA Schools of Thoracic Oncology - Worldwide Virtual Event on December 3-4, 2021, the largest thoracic oncology event in LATAM!

The program includes sessions across four schools including: Thoracic Oncology, Nursing & Allied Health Professionals, Advocacy, and Pathology; A panel of experts will highlight palliative care and pain management best practices, medical ma*****na controversies and cancer indications, integrative medicine in the region, and a LIVE Q&A. Early Registration closes November 10, 2021. You can view the Program and/or Register Here: http://ow.ly/55DD50GubKi #LALCA21

Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with ...
10/19/2021

Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with #SCLC. Guests include Dr. Lauren Byers, associate professor of Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Ponce Aix, from the Gustave Roussy in Paris, France. Listen Now: http://ow.ly/qZNV50Gu934 #LCSM #lungcancer

Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with #SCLC. Guests include Dr. Lauren Byers, associate professor of Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Ponce Aix, from the Gustave Roussy in Paris, France. Listen Now: http://ow.ly/qZNV50Gu934 #LCSM #lungcancer

@IASLC #TTLC22 Meeting Chairs invite you to Save the Date for this dynamic meeting from Feb 23-26, 2022. Presenters will...
10/19/2021

@IASLC #TTLC22 Meeting Chairs invite you to Save the Date for this dynamic meeting from Feb 23-26, 2022. Presenters will summarize data on relevant targets for new therapies & share data on preclinical and early clinical data for each of the drugs directed against these targets. http://ow.ly/dv0q50Gthwl #LCSM

@IASLC #TTLC22 Meeting Chairs invite you to Save the Date for this dynamic meeting from Feb 23-26, 2022. Presenters will summarize data on relevant targets for new therapies & share data on preclinical and early clinical data for each of the drugs directed against these targets. http://ow.ly/dv0q50Gthwl #LCSM

Watch the #WCLC21 Presentation by Dr. Jamie Ostroff and Dr. Smita Banerjee "Talk About Solutions: Empathetic Communicati...
10/19/2021
WCLC 2021 Talk About Solutions in Lung Cancer Stigma

Watch the #WCLC21 Presentation by Dr. Jamie Ostroff and Dr. Smita Banerjee "Talk About Solutions: Empathetic Communication Module, Language Guide, Projects and Deliverables in Stigma with Attention to the Intersection of Patients, Clinicians, and Researchers": http://ow.ly/4C5t50Gt3Km #LCSM

Watch the WCLC 2021 Presentation by Dr. Jamie Ostroff and Dr. Smita Banerjee Talk About Solutions: Empathetic Communication Module, Language Guide, Projects ...

We are thrilled to announce that the European Lung Cancer Congress (ELCC), taking place as an onsite event in Prague, Cz...
10/18/2021

We are thrilled to announce that the European Lung Cancer Congress (ELCC), taking place as an onsite event in Prague, Czech Republic, on 30 March-2 April 2022, will also provide online access to its delegates. And, in other great news – the abstract submission system is now open, so get ready to connect to this highly interactive meeting and share your expertise with lung cancer specialists from all over the world. Learn more: http://ow.ly/Fj3450Gt8S6 #ELCC22 #LCSM

We are thrilled to announce that the European Lung Cancer Congress (ELCC), taking place as an onsite event in Prague, Czech Republic, on 30 March-2 April 2022, will also provide online access to its delegates. And, in other great news – the abstract submission system is now open, so get ready to connect to this highly interactive meeting and share your expertise with lung cancer specialists from all over the world. Learn more: http://ow.ly/Fj3450Gt8S6 #ELCC22 #LCSM

Watch this two-part activity exploring recent developments on the use of frontline immunotherapeutic strategies in patie...
10/18/2021

Watch this two-part activity exploring recent developments on the use of frontline immunotherapeutic strategies in patients with advanced #NSCLC. Filmed following the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting and European Society for Medical Oncology (ESMO) Congress 2021. Watch Now: http://ow.ly/Gylz50Gt4r2 #LCSM

Watch this two-part activity exploring recent developments on the use of frontline immunotherapeutic strategies in patients with advanced #NSCLC. Filmed following the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting and European Society for Medical Oncology (ESMO) Congress 2021. Watch Now: http://ow.ly/Gylz50Gt4r2 #LCSM

Watch Jill Feldman's #WCLC21 presentation on how stigmatizing words can affect patients and their families: http://ow.ly...
10/15/2021
WCLC 2021 Words Matter

Watch Jill Feldman's #WCLC21 presentation on how stigmatizing words can affect patients and their families: http://ow.ly/XQYU50GsjT7 #LCSM

Watch Jill Feldman's WCLC 2021 presentation on how stigmatizing words can affect patients and their families.

Gene fusions are established targets in #NSCLC, for which highly effective & well-tolerated kinase inhibitors are the pr...
10/15/2021
The eNRGy1 Global Multicenter Registry: NRG1 Fusions as a Hidden Target in Lung Cancer | IASLC

Gene fusions are established targets in #NSCLC, for which highly effective & well-tolerated kinase inhibitors are the preferred initial therapy. A growing body of evidence suggests fusions in NRG1 will emerge as another relevant genomic target. More: http://ow.ly/I5Ge50GsjNA #LCSM

Gene fusions involving ALK, ROS1, RET, and NTRK are now established targets in NSCLC, for which highly effective and well-tolerated kinase inhibitors are the pr ...

The WCLC21, the leading gathering of international scientists, researchers, and patient advocates in the field of lung c...
10/15/2021

The WCLC21, the leading gathering of international scientists, researchers, and patient advocates in the field of lung cancer and thoracic malignancies, was held from September 8-14, 2021. You can still access all recordings including Plenaries, Educational & Scientific Sessions, Workshops, Featured Posters, and more until Friday, December 17, 2021! Access the recordings or claim your CME credits today at https://wclc2021.iaslc.org/

The WCLC21, the leading gathering of international scientists, researchers, and patient advocates in the field of lung cancer and thoracic malignancies, was held from September 8-14, 2021. You can still access all recordings including Plenaries, Educational & Scientific Sessions, Workshops, Featured Posters, and more until Friday, December 17, 2021! Access the recordings or claim your CME credits today at https://wclc2021.iaslc.org/

In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne...
10/14/2021
ESMO Highlights with Dr. Solange Peters and Dr. Pasi Janne | IASLC

In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne, co-chair of ESMO 2021, discuss the recently concluded ESMO meeting and share the meeting’s most significant #lungcancer research findings with podcast host Dr. Narjust Duma. Listen Now: http://ow.ly/keL750GrBUW #LCSM

In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne, co-chair of ESMO 2021, discuss the ...

Register today for #LALCA22! There are several unique, intense workshops from various disciplines, designed for young re...
10/14/2021

Register today for #LALCA22! There are several unique, intense workshops from various disciplines, designed for young researchers in Latin America. The early-stage panel will review new developments in #NSCLC including the role of targeted therapy. http://ow.ly/oJBG50Gr6KJ #LCSM

Register today for #LALCA22! There are several unique, intense workshops from various disciplines, designed for young researchers in Latin America. The early-stage panel will review new developments in #NSCLC including the role of targeted therapy. http://ow.ly/oJBG50Gr6KJ #LCSM

In the National Lung Screening Trial, screening w/2 yrs of annual LDCT achieved a 20% decrease in #lungcancer mortality ...
10/13/2021
Balancing the Benefits and Harms of Lung Cancer Screening | IASLC

In the National Lung Screening Trial, screening w/2 yrs of annual LDCT achieved a 20% decrease in #lungcancer mortality in high-risk populations compared w/chest radiography. Recently the USPSTF expanded eligibility for adults ages 50-80. Read More: http://ow.ly/8pNz50Gq0XY #LCSM

In the National Lung Screening Trial, screening with 2 years of annual low-dose computed tomography (LDCT) achieved a 20% decrease in lung cancer mortality in h ...

CURE is pleased that award winning actress and filmmaker Laura Dern will deliver this year’s keynote address at the 2021...
10/13/2021

CURE is pleased that award winning actress and filmmaker Laura Dern will deliver this year’s keynote address at the 2021 Lung Cancer Heroes virtual celebration, part of IASLC's #SCLC21! Don’t miss this memorable evening on Thursday 10/28. RSVP today! http://ow.ly/eTWu50GpFj7 #LCSM

CURE is pleased that award winning actress and filmmaker Laura Dern will deliver this year’s keynote address at the 2021 Lung Cancer Heroes virtual celebration, part of IASLC's #SCLC21! Don’t miss this memorable evening on Thursday 10/28. RSVP today! http://ow.ly/eTWu50GpFj7 #LCSM

Articles published in the JTO Clinical and Research Reports  (JTO CRR) are now indexed and available through PubMed Cent...
10/12/2021

Articles published in the JTO Clinical and Research Reports (JTO CRR) are now indexed and available through PubMed Central (PMC). PMC is a free archive of biomedical and life sciences journal literature at the United States National Institutes of Health’s National Library of Medicine (NIH/NLM).

Since its founding in 2000, PMC has acted as a resource for quality scholarship from around the world. Currently, it hosts an archive of millions of articles that come from thousands of journals. Learn More> http://ow.ly/bRWC50GpDW2 #LCSM

Articles published in the JTO Clinical and Research Reports (JTO CRR) are now indexed and available through PubMed Central (PMC). PMC is a free archive of biomedical and life sciences journal literature at the United States National Institutes of Health’s National Library of Medicine (NIH/NLM).

Since its founding in 2000, PMC has acted as a resource for quality scholarship from around the world. Currently, it hosts an archive of millions of articles that come from thousands of journals. Learn More> http://ow.ly/bRWC50GpDW2 #LCSM

#SCLC21 will be held as a Worldwide Virtual Event Oct 29-30, 2021. Keynote speaker Prof. Caroline Dive from the Cancer R...
10/12/2021

#SCLC21 will be held as a Worldwide Virtual Event Oct 29-30, 2021. Keynote speaker Prof. Caroline Dive from the Cancer Research UK - Manchester Institute (Oxford, UK) will present: "Lessons from CDX Models in #SCLC". Only 2 weeks left, Register Now> http://ow.ly/5LcS50GpD9e #LCSM

#SCLC21 will be held as a Worldwide Virtual Event Oct 29-30, 2021. Keynote speaker Prof. Caroline Dive from the Cancer Research UK - Manchester Institute (Oxford, UK) will present: "Lessons from CDX Models in #SCLC". Only 2 weeks left, Register Now> http://ow.ly/5LcS50GpD9e #LCSM

WCLC 2021 MEETING NEWS is the official newspaper of #WCLC21, published before, during, and after the meeting. Don't miss...
10/08/2021

WCLC 2021 MEETING NEWS is the official newspaper of #WCLC21, published before, during, and after the meeting. Don't miss an issue! http://ow.ly/sxht50Go11r #LCSM

WCLC 2021 MEETING NEWS is the official newspaper of #WCLC21, published before, during, and after the meeting. Don't miss an issue! http://ow.ly/sxht50Go11r #LCSM

Use of patient-friendly, common umbrella terms to discuss #biomarker & genetic testing may improve understanding, commun...
10/07/2021

Use of patient-friendly, common umbrella terms to discuss #biomarker & genetic testing may improve understanding, communication & shared decision-making for patients and doctors. New #JCOPO manuscript: http://ow.ly/k2XB50GnKcC #precisionmedicine #genetictesting #biomarkertesting

Use of patient-friendly, common umbrella terms to discuss #biomarker & genetic testing may improve understanding, communication & shared decision-making for patients and doctors. New #JCOPO manuscript: http://ow.ly/k2XB50GnKcC #precisionmedicine #genetictesting #biomarkertesting

Surgical resection remains the gold standard for patients diagnosed w/early-stage #lungcancer; Since the early 1990s, VA...
10/07/2021
Adoption of VATS Continues to Vary Globally | IASLC

Surgical resection remains the gold standard for patients diagnosed w/early-stage #lungcancer; Since the early 1990s, VATS lobectomy has been acknowledged as an effective (and preferred) minimally invasive approach for lung cancer surgery. Read More: http://ow.ly/AUJ150GnhPY #LCSM

Surgical resection remains the gold standard for patients diagnosed with early-stage lung cancer, and since the early 1990s, video-assisted thoracoscopic surger ...

The intersection of medicine and politics is fascinating and often controversial and contentious.  In this episode of Lu...
10/06/2021

The intersection of medicine and politics is fascinating and often controversial and contentious. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks to two physicians who have entered the political arena—Dr. Nasser Hanna, who ran in Indiana’s 5th Congressional District and Dr. Raja Flores, who is running for Mayor of New York City. Listen Here: http://ow.ly/LOdk50GnbKP. #LCSM

The intersection of medicine and politics is fascinating and often controversial and contentious. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks to two physicians who have entered the political arena—Dr. Nasser Hanna, who ran in Indiana’s 5th Congressional District and Dr. Raja Flores, who is running for Mayor of New York City. Listen Here: http://ow.ly/LOdk50GnbKP. #LCSM

The IASLC is proud to support and partner with various patient advocacy groups, patient research advocates, and patient ...
10/06/2021
Patient Advocacy | IASLC

The IASLC is proud to support and partner with various patient advocacy groups, patient research advocates, and patient advocates from around the globe. Lean More: https://www.iaslc.org/patient-advocacy

Amplifying the patient voice to improve the speed and quality of research. The IASLC is proud to support and partner with various patient advocacy groups, patie ...

REGISTER NOW! #LALCA21 will host workshops from different disciplines including thoracic oncology, advocacy, AHP, & path...
10/05/2021

REGISTER NOW! #LALCA21 will host workshops from different disciplines including thoracic oncology, advocacy, AHP, & pathology, specifically designed for young researchers in #LatinAmerica. Learn more: http://ow.ly/A18M50Gml6n

REGISTER NOW! #LALCA21 will host workshops from different disciplines including thoracic oncology, advocacy, AHP, & pathology, specifically designed for young researchers in #LatinAmerica. Learn more: http://ow.ly/A18M50Gml6n

Management of CNS metastases in patients with driver-mutated #NSCLC has traditionally incorporated both TKIs and intracr...
10/01/2021

Management of CNS metastases in patients with driver-mutated #NSCLC has traditionally incorporated both TKIs and intracranial radiation. Whether next generation, CNS-penetrant TKIs can be used alone without upfront radiation, however, remains unknown. Learn More: http://ow.ly/IyxF50GiYu1 #LCSM

Management of CNS metastases in patients with driver-mutated #NSCLC has traditionally incorporated both TKIs and intracranial radiation. Whether next generation, CNS-penetrant TKIs can be used alone without upfront radiation, however, remains unknown. Learn More: http://ow.ly/IyxF50GiYu1 #LCSM

Address

999 17th Street, Suite 200
Denver, CO
80202

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Products

Journal of Thoracic Oncology | https://www.jto.org/

Alerts

Be the first to know and let us send you an email when International Association for the Study of Lung Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to International Association for the Study of Lung Cancer:

Videos

About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is on a mission to conquer thoracic cancers worldwide. Through hosting global conferences, funding cutting-edge research and educating the health care community and the general public on all aspects of thoracic cancers, the IASLC strives to alleviate the burden lung cancer places on patients, families and communities.

Each year, the IASLC hosts the World Conference on Lung Cancer (WCLC), the world’s largest meeting dedicated solely to thoracic cancers. The WCLC regularly attracts over 7,000 thoracic cancer specialists from over 100 countries and offers attendees the chance to collaborate and network while learning about the latest updates in the field.

The IASLC Foundation supports the education of research fellows - who are the next generation of lung cancer physicians and scientists - by funding research fellowships. Since its inception, the foundation has given nearly $3.5 million to lung cancer research, and that number is on the rise.

Additionally, the IASLC publishes the Journal of Thoracic Oncology (JTO), a primary source for educational information related to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Over its publication history, the JTO has established itself as an authoritative resource in the field, and the journal recently saw its impact factor increase from 6.595 in 2016 to 10.336 in 2017.

Nearby health & beauty businesses


Other Medical & Health in Denver

Show All

Comments

#LCSM Chat on Twitter is this Thursday 10/7 at 5pm PT, 8pm ET. Our topic is “Best in Show” - Lung Cancer highlights from the 2021 World Conference on Lung Cancer and the European Society for Medical Oncology," moderated by thoracic oncologist Charu Aggarwal, MD. IMPORTANT: READ MORE HERE PRIOR TO CHAT: https://lcsmchat.com/2021/10/04/lcsm-chat-topic-07-oct-2021-best-in-show-lung-cancer-highlights-from-wclc21-esmo21/ Please join us, and share to spread the word!
*Assalamu'alaikum, greetings and peace* Without prejudice to respect for Mr / Mrs and my brothers and sisters without exception. Please be willing to be willing to extend a rope of love for our brother *(Jacky) Sutranianto* who is currently suffering from brain cancer and to ease the burden on his family and also for medical expenses. May the love that we extend get an abundant reply from Allah SWT / Almighty God. Amen.. NB: Nominal is not a definite measure, we hope that we care for others... Good people, help is really needed, help our brother Sutrannianto, Taylor's employees and we ask for prayers to all of you for healing from cancer of the nasal cavity has reached the stage IV and to ease the grief of his wife and family. Please help Donate by clicking https://kitabisa.com/319060?utm_source=socialsharing_campaigner_web_3bb107dd18f80d62fc7cb92dcefddb77&utm_medium=share_campaign_whatsapp&utm_campaign=share_detail_campaign or through the website: www.yayasansedulurwaridha.org Thus and thank you infinite for your contribution and concern 🙏🙏
Registration is open for the 7th International Summit on Cancer Research and Diagnosis held on October 29-30, 2021 at #NewYork, #USA and get a chance to meet with global experts. #cancer #conference #research #health #clinicalresearchers
Liquid biopsy in early detection, treatment decisions, and monitoring is our topic for #LCSM Chat on Twitter this Thursday March 4th at 5pm PT, 8pm ET. Please join us for “Liquid Biopsy: It pays to be vein” with special guests Dr Charu Aggarwal and Dr Lecia Sequist. ALL CANCERS CHAT! Please join us and spread the word.
Focus back of targeted therapy this year @WCLC19.love it!!!
World Conference Thought Leader Interview: In this video, hear from Dr. Ray Osarogiagbon as he discusses some of his favorite moments so far from #WCLC19. #LCSM
Last night at the IASLC 2019 World Conference on Lung Cancer (#WCLC19) Opening Ceremony, our President, Dr. Giorgio Scagliotti, shared that his first WCLC memory was Interlaken, Switzerland. What was yours? Share it with us by stopping by our frame in the registration area adjacent to the social media booth. Take a photo of yourself in the frame, write down the first time you attended a WCLC and share it as a post on your favorite social platform with the hashtag: #MyFirstWCLC. #LCSM
At this year's World Conference on Lung Cancer (#WCLC19), we once again awarded the IASLC Cancer Care Team Award, an honor designed to celebrate the work of a multidisciplinary cancer care team that has provided extraordinary cancer care. This unique award celebrates teams from across the world, and is a patient-nominated award. In 2019, the overall winner was the Postgraduate Institute of Medical Education and Research, with team members including Navneet Singh, Amanjit Bal, K.T. Prasad, Nalini Gupta, Rakesh Kapoor and others. #LCSM
Our official journal, the Journal of Thoracic Oncology (JTO), is launching a new IASLC journal, ensuring the organization's efforts to remain the leading authority on thoracic malignancies. The journal is titled: JTO Clinical and Research Reports (JTOCRR). In this video, the Editor-in-Chief of both the JTO and the JTOCRR, Dr. Alex Adjei, introduces the new journal. Be sure to also check out its new webpage to learn more: https://www.jto.org/jtocrr. #LCSM
For over 40 years, the IASLC World Conference on Lung Cancer (WCLC) has been the nexus for the international lung cancer community, bringing people from across the world to connect, grow and learn with/from one another. With little more than one week left before we celebrate our 20th WCLC, hear from our former CEO, Dr. Paul Bunn, on the event's enduring impact. #LCSM #LungCancer Learn more about #WCLC19 --> https://wclc2019.iaslc.org/
Hi all! My name is Cristina and I work at Global Patients where we are currently developing a scientific study about lung cancer We are looking for people living in the US suffering from Lung Cancer (Stage IV) to share their experiences during a 25min online survey. The purpose of this survey is to better understand the trade-offs patients may make among potential benefits and risks associated with imaginary NSCLC therapies. Participants will receive $75 for their time. Patients’ data will be kept completely confidential If you are interested and want to help please contact me on fbook or at cristina @ global-patients. com Many thanks and wishing you a nice day!
Help me to safe a live...it's only 1 life and might not change the world for you, but for me it does. Since 25 years we are married and now CANCER is trying to take her away from me.. please read , share and help me to get the treatment she deserves http://ningbolife.com/blog/.... please note that I have very limited access to Facebook here in China. Please communicate via the website. English and German is fine. PS: You can translate the webpage via browse translate plugin/ communicate also by email [email protected]